These data emphasize the importance of the S1PR1,R5 pathway in the development of disease in this model and highlight S1PR1 modulation as a novel and exciting mechanism for the treatment of patients with SLE. This evidence concerns the gene S1PR1 and systemic lupus erythematosus.